The LifePort Kidney Transporter perfuses one or two donor kidneys with a cold sterile solution while they travel between recovery and transplant hospitals. Its display presents live pressure, temperature, flow, and renal resistance readings that clinicians use to judge organ behavior, perfusion data remains available for review after a run, and a web portal and mobile app extend access to metrics and shipment tracking while organs are en route.

Organ Recovery Systems positions LifePort as an incumbent standard for kidney machine preservation, reporting hundreds of thousands of kidneys perfused since the device line launched in 2003 and use across more than 400 transplant programs in 49 countries. In the ex-situ kidney perfusion and assessment market it competes with XVIVO's Kidney Assist Transport and Waters Medical Systems' RM4, and its metrics-driven workflow is the decision layer that AI-based assessment tools such as BMI OrganBank's planned BMI OrganIQ intend to augment.